Billionaire Profile
Cyrus Poonawalla
Global Rank
#118

Image: Public domain | via Wikimedia Commons

Cyrus Poonawalla

CEO, Serum Institute of India
IN
Real-Time Net Worth
$20.9B
As of December 2025
Age
84
Source
Vaccines
Industry
healthcare
Citizenship
IN

Biography

Cyrus Poonawalla, an Indian billionaire businessman, is the chairman and managing director of the Cyrus Poonawalla Group. He is best known for founding the Serum Institute of India (SII), the world's largest vaccine manufacturer by dose volume. Poonawalla's career began in 1966 when he established the Serum Institute, initially to produce life-saving immunobiologicals. Over the years, the company has expanded its portfolio and global reach, contributing significantly to global healthcare, particularly in making vaccines affordable. His net worth is estimated at $20.9 billion, making him one of the wealthiest individuals in India.

Wealth Over Time

In-Depth Profile

Early Life

Cyrus Soli Poonawalla was born on May 11, 1941, into a Parsi family in Pune, India. His father, Soli Poonawalla, was a horse breeder, and the family owned the Poonawalla Stud Farms. Cyrus attended The Bishop's School in Pune and later graduated from Brihan Maharashtra College of Commerce (BMCC).

Rise to Success

In 1966, at the age of 25, Cyrus Poonawalla founded the Serum Institute of India (SII) with the goal of producing affordable vaccines. The company initially focused on producing tetanus antitoxin and anti-snake venom serum. Over time, SII expanded its product range to include vaccines for measles, mumps, rubella, polio, hepatitis, and influenza. Under his leadership, the Serum Institute became the world's largest vaccine manufacturer by volume.

Key Business Strategies

Poonawalla's business strategy focused on producing high-quality vaccines at affordable prices, making them accessible to a large population. This approach enabled SII to secure contracts with organizations like UNICEF and PAHO and expand its reach to over 140 countries. The Serum Institute's capacity to rapidly scale up production, as demonstrated during the COVID-19 pandemic with the Covishield vaccine, has been another key factor in its success.

Philanthropy

Beyond his business achievements, Cyrus Poonawalla is known for his philanthropic efforts in healthcare and education. He has contributed to infrastructure development in India and supported various charitable initiatives.

Career Milestones

1966

Founded Serum Institute of India

Established the Serum Institute of India to produce life-saving immunobiologicals.

2005

Padma Shri

Awarded the Padma Shri for his contribution to medicine.

2022

Padma Bhushan

Awarded the Padma Bhushan for his contribution to vaccine production during COVID-19

Philanthropy & Social Impact

Healthcare, Education, Welfare

Villoo Poonawalla Foundation

Undisclosed

Supports healthcare, education, and public welfare

Business Philosophy & Leadership

Notable Quotes

"Cyrus Poonawalla's major works include the production of the MMR (measles, mumps, and rubella) vaccine and the development of the MenAfriVac, which helped eradicate meningitis A in Africa."

Leadership Principles

Innovation

Continuously seeking new ways to improve vaccine production and healthcare solutions.

Affordability

Making vaccines accessible to a wide range of people, especially in low and middle-income countries.

Quality

Maintaining high standards in vaccine production and adhering to regulatory guidelines.

Controversies & Challenges

2020

Covishield Vaccine Trial

A volunteer in Chennai alleged adverse effects from the Covishield vaccine trial; Serum Institute refuted the allegations and filed a defamation suit.